JP2018514209A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514209A5
JP2018514209A5 JP2017555767A JP2017555767A JP2018514209A5 JP 2018514209 A5 JP2018514209 A5 JP 2018514209A5 JP 2017555767 A JP2017555767 A JP 2017555767A JP 2017555767 A JP2017555767 A JP 2017555767A JP 2018514209 A5 JP2018514209 A5 JP 2018514209A5
Authority
JP
Japan
Prior art keywords
nucleic acid
signal peptide
acid construct
cell
hydrophobic amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017555767A
Other languages
English (en)
Japanese (ja)
Other versions
JP6836516B2 (ja
JP2018514209A (ja
Filing date
Publication date
Priority claimed from GBGB1507108.7A external-priority patent/GB201507108D0/en
Application filed filed Critical
Publication of JP2018514209A publication Critical patent/JP2018514209A/ja
Publication of JP2018514209A5 publication Critical patent/JP2018514209A5/ja
Application granted granted Critical
Publication of JP6836516B2 publication Critical patent/JP6836516B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017555767A 2015-04-27 2016-04-26 核酸構築物 Active JP6836516B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1507108.7 2015-04-27
GBGB1507108.7A GB201507108D0 (en) 2015-04-27 2015-04-27 Nucleic acid construct
PCT/GB2016/051165 WO2016174409A1 (en) 2015-04-27 2016-04-26 Nucleic acid construct

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020117041A Division JP2020182473A (ja) 2015-04-27 2020-07-07 核酸構築物

Publications (3)

Publication Number Publication Date
JP2018514209A JP2018514209A (ja) 2018-06-07
JP2018514209A5 true JP2018514209A5 (2) 2019-04-11
JP6836516B2 JP6836516B2 (ja) 2021-03-03

Family

ID=53488690

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017555767A Active JP6836516B2 (ja) 2015-04-27 2016-04-26 核酸構築物
JP2020117041A Withdrawn JP2020182473A (ja) 2015-04-27 2020-07-07 核酸構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020117041A Withdrawn JP2020182473A (ja) 2015-04-27 2020-07-07 核酸構築物

Country Status (10)

Country Link
US (1) US11613559B2 (2)
EP (1) EP3288582B1 (2)
JP (2) JP6836516B2 (2)
CN (1) CN107532175A (2)
AU (1) AU2016254499A1 (2)
CA (1) CA2983687A1 (2)
ES (1) ES2869971T3 (2)
GB (1) GB201507108D0 (2)
HK (1) HK1243958A1 (2)
WO (1) WO2016174409A1 (2)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3143134T3 (da) 2014-05-15 2021-01-04 Nat Univ Singapore Modificerede, naturlige dræberceller og anvendelser deraf
CA3056591A1 (en) 2017-03-27 2018-10-04 National University Of Singapore Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
BR112019019917A2 (pt) 2017-03-27 2020-04-22 Nat Univ Singapore receptores quiméricos nkg2d truncados e seus usos em imunoterapia de células exterminadoras naturais
US20210130775A1 (en) * 2017-08-02 2021-05-06 Autolus Limited Cells expressing a chimeric antigen receptor or engineered tcr and comprising a nucleotide sequence which is selectively expressed
EP3749685A4 (en) 2018-02-09 2021-12-22 National University of Singapore ACTIVATOR CHEMERIC RECEPTORS AND THEIR USES IN NATURAL KILLING CELL IMMUNOTHERAPY
JP7334985B2 (ja) 2018-04-02 2023-08-29 ナショナル ユニヴァーシティー オブ シンガポール 免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和
GB201805918D0 (en) 2018-04-10 2018-05-23 Autolus Ltd Cell
GB201812474D0 (en) * 2018-07-31 2018-09-12 Autolus Ltd Nucleic acid construct
EP3844186A4 (en) 2018-08-29 2022-08-17 National University of Singapore METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
CA3120563A1 (en) 2018-11-26 2020-06-04 Nkarta, Inc. Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
EP3773918A4 (en) 2019-03-05 2022-01-05 Nkarta, Inc. CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
GB201914611D0 (en) 2019-10-09 2019-11-20 Autolus Ltd Engineered immune cell
GB202007044D0 (en) 2020-05-13 2020-06-24 Autolus Ltd Method
JP2022072823A (ja) 2020-10-30 2022-05-17 藤森工業株式会社 包装袋
AR124414A1 (es) 2020-12-18 2023-03-22 Century Therapeutics Inc Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
GB202108184D0 (en) 2021-06-08 2021-07-21 Autolus Ltd Engineered immune cell
WO2023139360A1 (en) 2022-01-19 2023-07-27 Autolus Limited Nucleic acid construct

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000063374A1 (en) 1999-04-16 2000-10-26 Celltech Therapeutics Limited Synthetic transmembrane components
MX2008000985A (es) * 2005-07-21 2008-04-07 Abbott Lab Expresion de gen multiple que incluye construcciones y metodos sorf (cuadro de lectura abierta simple) con poliproteinas, pro-proteinas y proteolisis.
EP2496601B1 (en) * 2009-11-05 2017-06-07 F. Hoffmann-La Roche AG Methods and composition for secretion of heterologous polypeptides
CN103483452B (zh) * 2012-06-12 2021-08-13 上海细胞治疗集团有限公司 双信号独立的嵌合抗原受体及其用途
GB201317929D0 (en) 2013-10-10 2013-11-27 Ucl Business Plc Chimeric antigen receptor
MX373687B (es) 2013-11-21 2020-07-07 Ucl Business Ltd Célula natural (nk)
GB201507104D0 (en) 2015-04-27 2015-06-10 Ucl Business Plc Nucleic acid construct

Similar Documents

Publication Publication Date Title
JP2018514209A5 (2)
ES2869971T3 (es) Construcción de ácido nucleico
JP2018514208A5 (2)
JP2017512063A5 (2)
EP3601367B1 (en) Chimeric molecules and uses thereof
Kinney et al. Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins
JP2017509335A5 (2)
Kirchhausen et al. Linking cargo to vesicle formation: receptor tail interactions with coat proteins
JP2014506790A5 (2)
JP2005120106A5 (2)
RU2013140685A (ru) ВАРИАНТЫ Fc, СПОСОБЫ ИХ ПОЛУЧЕНИЯ
JP2017070289A5 (2)
ES2710936T3 (es) Método para preparar una mezcla de proteínas homodiméricas usando efecto de repulsión de carga
JP2016533174A5 (2)
JP2020529841A5 (2)
JP2017514522A5 (2)
JP2019522466A5 (2)
JP2015514811A5 (2)
JP2016501535A5 (2)
JP2019516665A5 (2)
RU2017132978A (ru) Химерный рецептор антигена
IL294059A (en) Mutant rsv f protein and its use
RU2019139064A (ru) Композиции и способы для лечения цитомегаловируса
FI3730612T3 (fi) Immunokompetentti solu, joka ilmaisee erityisesti ihmisen mesoteliinin, il-7:n ja ccl19:n tunnistavan solukalvon molekyylin
WO2008138649A3 (en) Signaling peptides